Chinese General Practice ›› 2023, Vol. 26 ›› Issue (25): 3163-3169.DOI: 10.12114/j.issn.1007-9572.2023.0236
• Original Research·Digital and Intelligent Healthcare • Previous Articles Next Articles
Received:
2023-01-11
Revised:
2023-05-21
Published:
2023-09-05
Online:
2023-05-31
Contact:
FEI Xiaolu
通讯作者:
费晓璐
作者简介:
基金资助:
项目 | 患者依从性评价 | 处方适宜性评价 | 处方经济性评价 | 服药告知与提醒 | 服药注意事项 | 服药记录管理 |
---|---|---|---|---|---|---|
非常应该 | 17 368(58.87) | 17 625(59.74) | 17 033(57.74) | 17 875(60.59) | 19 388(65.72) | 14 320(48.54) |
应该 | 9 342(31.67) | 10 009(33.93) | 10 206(34.59) | 8 548(28.97) | 8 505(28.83) | 10 063(34.11) |
无所谓 | 1 861(6.31) | 1 238(4.20) | 1 521(5.16) | 1 485(5.03) | 748(2.54) | 2 904(9.84) |
不应该 | 819(2.78) | 538(1.82) | 639(2.17) | 1 444(4.89) | 752(2.55) | 2047(6.94) |
非常不应该 | 112(0.38) | 92(0.31) | 103(0.35) | 150(0.51) | 109(0.37) | 168(0.57) |
项目 | 潜在用药问题提醒 | 人工实时咨询 | 人工非实时咨询 | 自助查询 | 提醒服药 | 记录分析 |
非常应该 | 17 175(58.22) | 16 233(55.02) | 13 924(47.20) | 16 000(54.23) | 14 199(48.13) | 17 134(58.08) |
应该 | 10 389(35.21) | 11 366(38.53) | 12 466(42.25) | 12 075(40.93) | 11 101(37.63) | 10 858(36.80) |
无所谓 | 942(3.19) | 1 457(4.94) | 2 078(7.04) | 1 027(3.48) | 2 891(9.80) | 1 098(3.72) |
不应该 | 885(3.00) | 372(1.26) | 849(2.88) | 327(1.11) | 1 210(4.10) | 316(1.07) |
非常不应该 | 111(0.38) | 74(0.25) | 185(0.63) | 73(0.25) | 101(0.34) | 96(0.33) |
Table 1 The distribution of respondents' evaluation of the importance of each function of the platform
项目 | 患者依从性评价 | 处方适宜性评价 | 处方经济性评价 | 服药告知与提醒 | 服药注意事项 | 服药记录管理 |
---|---|---|---|---|---|---|
非常应该 | 17 368(58.87) | 17 625(59.74) | 17 033(57.74) | 17 875(60.59) | 19 388(65.72) | 14 320(48.54) |
应该 | 9 342(31.67) | 10 009(33.93) | 10 206(34.59) | 8 548(28.97) | 8 505(28.83) | 10 063(34.11) |
无所谓 | 1 861(6.31) | 1 238(4.20) | 1 521(5.16) | 1 485(5.03) | 748(2.54) | 2 904(9.84) |
不应该 | 819(2.78) | 538(1.82) | 639(2.17) | 1 444(4.89) | 752(2.55) | 2047(6.94) |
非常不应该 | 112(0.38) | 92(0.31) | 103(0.35) | 150(0.51) | 109(0.37) | 168(0.57) |
项目 | 潜在用药问题提醒 | 人工实时咨询 | 人工非实时咨询 | 自助查询 | 提醒服药 | 记录分析 |
非常应该 | 17 175(58.22) | 16 233(55.02) | 13 924(47.20) | 16 000(54.23) | 14 199(48.13) | 17 134(58.08) |
应该 | 10 389(35.21) | 11 366(38.53) | 12 466(42.25) | 12 075(40.93) | 11 101(37.63) | 10 858(36.80) |
无所谓 | 942(3.19) | 1 457(4.94) | 2 078(7.04) | 1 027(3.48) | 2 891(9.80) | 1 098(3.72) |
不应该 | 885(3.00) | 372(1.26) | 849(2.88) | 327(1.11) | 1 210(4.10) | 316(1.07) |
非常不应该 | 111(0.38) | 74(0.25) | 185(0.63) | 73(0.25) | 101(0.34) | 96(0.33) |
成分 | 初始特征值 | 提取载荷平方和 | ||||
---|---|---|---|---|---|---|
总计 | 方差解释率(%) | 累积方差解释率(%) | 总计 | 方差解释率(%) | 累积方差解释率(%) | |
1 | 6.856 | 57.136 | 57.136 | 6.856 | 57.136 | 57.136 |
2 | 1.043 | 8.694 | 65.830 | 1.043 | 8.694 | 65.830 |
3 | 0.821 | 6.842 | 72.672 | 0.821 | 6.842 | 72.672 |
4 | 0.494 | 4.119 | 76.791 | 0.494 | 4.119 | 76.791 |
5 | 0.462 | 3.854 | 80.645 | |||
6 | 0.430 | 3.581 | 84.226 | |||
7 | 0.417 | 3.473 | 87.699 | |||
8 | 0.357 | 2.978 | 90.677 | |||
9 | 0.349 | 2.912 | 93.589 | |||
10 | 0.271 | 2.260 | 95.849 | |||
11 | 0.257 | 2.145 | 97.994 | |||
12 | 0.241 | 2.006 | 100.000 |
Table 2 Explanation of the total variance of each factor
成分 | 初始特征值 | 提取载荷平方和 | ||||
---|---|---|---|---|---|---|
总计 | 方差解释率(%) | 累积方差解释率(%) | 总计 | 方差解释率(%) | 累积方差解释率(%) | |
1 | 6.856 | 57.136 | 57.136 | 6.856 | 57.136 | 57.136 |
2 | 1.043 | 8.694 | 65.830 | 1.043 | 8.694 | 65.830 |
3 | 0.821 | 6.842 | 72.672 | 0.821 | 6.842 | 72.672 |
4 | 0.494 | 4.119 | 76.791 | 0.494 | 4.119 | 76.791 |
5 | 0.462 | 3.854 | 80.645 | |||
6 | 0.430 | 3.581 | 84.226 | |||
7 | 0.417 | 3.473 | 87.699 | |||
8 | 0.357 | 2.978 | 90.677 | |||
9 | 0.349 | 2.912 | 93.589 | |||
10 | 0.271 | 2.260 | 95.849 | |||
11 | 0.257 | 2.145 | 97.994 | |||
12 | 0.241 | 2.006 | 100.000 |
项目 | F1 | F2 | F3 | F4 |
---|---|---|---|---|
处方依从性评价 | 0.246 | 0.818 | 0.104 | 0.185 |
处方适宜性评价 | 0.268 | 0.835 | 0.205 | 0.135 |
处方经济性评价 | 0.257 | 0.744 | 0.257 | 0.130 |
告知与提醒 | 0.824 | 0.247 | 0.152 | 0.137 |
服药注意事项 | 0.774 | 0.270 | 0.274 | 0.113 |
记录管理服药 | 0.774 | 0.250 | 0.168 | 0.265 |
用药问题提醒 | 0.686 | 0.318 | 0.320 | 0.223 |
人工实时咨询 | 0.402 | 0.247 | 0.426 | 0.560 |
人工非实时咨询 | 0.240 | 0.210 | 0.243 | 0.869 |
自助查询 | 0.221 | 0.218 | 0.797 | 0.283 |
用药时间提醒 | 0.603 | 0.188 | 0.435 | 0.301 |
记录与分析不良反应 | 0.423 | 0.277 | 0.689 | 0.167 |
Table 3 Loading matrix of the 4 factors after rotation
项目 | F1 | F2 | F3 | F4 |
---|---|---|---|---|
处方依从性评价 | 0.246 | 0.818 | 0.104 | 0.185 |
处方适宜性评价 | 0.268 | 0.835 | 0.205 | 0.135 |
处方经济性评价 | 0.257 | 0.744 | 0.257 | 0.130 |
告知与提醒 | 0.824 | 0.247 | 0.152 | 0.137 |
服药注意事项 | 0.774 | 0.270 | 0.274 | 0.113 |
记录管理服药 | 0.774 | 0.250 | 0.168 | 0.265 |
用药问题提醒 | 0.686 | 0.318 | 0.320 | 0.223 |
人工实时咨询 | 0.402 | 0.247 | 0.426 | 0.560 |
人工非实时咨询 | 0.240 | 0.210 | 0.243 | 0.869 |
自助查询 | 0.221 | 0.218 | 0.797 | 0.283 |
用药时间提醒 | 0.603 | 0.188 | 0.435 | 0.301 |
记录与分析不良反应 | 0.423 | 0.277 | 0.689 | 0.167 |
项目 | F1 | F2 | F3 | F4 |
---|---|---|---|---|
处方依从性评价 | -0.113 | 0.511 | -0.219 | 0.044 |
处方适宜性评价 | -0.130 | 0.505 | -0.058 | -0.095 |
处方经济性评价 | -0.133 | 0.429 | 0.039 | -0.119 |
告知与提醒 | 0.461 | -0.077 | -0.238 | -0.107 |
服药注意事项 | 0.375 | -0.067 | -0.037 | -0.206 |
记录管理服药 | 0.388 | -0.081 | -0.271 | 0.078 |
用药问题提醒 | 0.254 | -0.030 | -0.012 | -0.062 |
人工实时咨询 | -0.056 | -0.074 | 0.062 | 0.433 |
人工非实时咨询 | -0.164 | -0.063 | -0.308 | 1.027 |
自助查询 | -0.266 | -0.084 | 0.821 | -0.141 |
用药时间提醒 | 0.165 | -0.140 | 0.159 | 0.018 |
记录与分析不良反应 | -0.062 | -0.057 | 0.648 | -0.297 |
Table 4 Coefficient matrix of the 4 factor scores
项目 | F1 | F2 | F3 | F4 |
---|---|---|---|---|
处方依从性评价 | -0.113 | 0.511 | -0.219 | 0.044 |
处方适宜性评价 | -0.130 | 0.505 | -0.058 | -0.095 |
处方经济性评价 | -0.133 | 0.429 | 0.039 | -0.119 |
告知与提醒 | 0.461 | -0.077 | -0.238 | -0.107 |
服药注意事项 | 0.375 | -0.067 | -0.037 | -0.206 |
记录管理服药 | 0.388 | -0.081 | -0.271 | 0.078 |
用药问题提醒 | 0.254 | -0.030 | -0.012 | -0.062 |
人工实时咨询 | -0.056 | -0.074 | 0.062 | 0.433 |
人工非实时咨询 | -0.164 | -0.063 | -0.308 | 1.027 |
自助查询 | -0.266 | -0.084 | 0.821 | -0.141 |
用药时间提醒 | 0.165 | -0.140 | 0.159 | 0.018 |
记录与分析不良反应 | -0.062 | -0.057 | 0.648 | -0.297 |
[1] |
|
[2] |
|
[3] |
张晓琳,周双,周颖,等. 老年人不适当用药的研究进展[J]. 中华老年医学杂志,2018,37(4):479-484.
|
[4] |
金福碧,郑和昕,林玲萍,等. 老年住院患者多重用药调查分析与对策[J]. 浙江中医药大学学报,2012,36(12):1360-1363.
|
[5] |
魏岚,黄跃,宋亚楠,等. 面向医疗专业人员的老年患者多重用药评价管理与咨询服务平台需求调研[J]. 中国全科医学,2023,26(25):3157-3162. DOI:10.12114/j.issn.1007-9572.2023.0235.
|
[6] |
潘婉玉,张春慧,张振香,等. 老年慢性病共病患者多重用药管理分析与评论[J]. 中国全科医学,2022,25(13):1545-1550. DOI:10.12114/j.issn.1007-9572.2022.00.009.
|
[7] |
舒冰,方玉婷,李民,等. 老年多重用药患者潜在不适当用药情况及其影响因素研究[J]. 中国全科医学,2021,24(17):2134-2139,2147. DOI:10.12114/j.issn.1007-9572.2021.00.489.
|
[8] |
苏斌斌,马金霞,宋伟,等. 中老年患者共病及多重用药情况分析[J]. 中华医学杂志,2020,100(25):1983-1987.
|
[9] |
|
[10] |
曲国红,智俊娜,陈龙保,等. 老年患者多重用药风险及其影响因素分析[J]. 药学与临床研究,2020,28(5):363-366.
|
[11] |
李凤,王建华,宋开兰. 老年病人多重用药的研究进展[J]. 护理研究,2020,34(23):4207-4210.
|
[12] |
李杨静,肖文文,赛娅热·雪克拉提,等. 老年综合评估在老年住院患者多重用药管理中的作用[J]. 新疆医学,2023,53(4):411-414,437.
|
[13] |
邓敏,尹畅,吴含达,等. 老年人群多重用药现状调查与分析[J]. 中国医院用药评价与分析,2022,22(10):1251-1254,1258. DOI:10.14009/j.issn.1672-2124.2022.10.021.
|
[14] |
刘葳,于德华,金花,等. 社区老年多病共存患者多重用药情况评价研究[J]. 中国全科医学,2020,23(13):1592-1598. DOI:10.12114/j.issn.1007-9572.2020.00.026.
|
[15] |
宋亚楠,魏岚,黄跃,等. 新冠肺炎疫情时期互联网诊疗的发展与实践[J]. 中国数字医学,2022,17(1):101-106.
|
[16] |
沈东平,牟雪菲,李俊伟,等. 基于"互联网+医疗"的慢病随访管理平台的设计与应用[J]. 中国数字医学,2019,14(5):49-51. DOI:10.3969/j.issn.1673-7571.2019.05.014.
|
[1] | ZHANG Qian, LI Shu, LI Pengmei. Interpretation of the 2023 AGS Beers Criteria: Potentially Inappropriate Medication Use in Older Adults [J]. Chinese General Practice, 2023, 26(35): 4372-4381. |
[2] | ZHONG Pingping, NAN Yayun, PENG Linlin, ZHOU Yuting, CHEN Qiong. A Bibliometrics Analysis of Polypharmacy in the Elderly from 2003 to 2022 [J]. Chinese General Practice, 2023, 26(35): 4404-4411. |
[3] | XIE Xuemei, GAO Jing, BAI Dingxi, LU Xianying, HE Jiali, LI Yue. Current Status of Polypharmacy in the Elderly and Its Influencing Factors: a Meta-analysis [J]. Chinese General Practice, 2023, 26(35): 4394-4403. |
[4] | XU Man, AN Zhuoling, ZHANG Yuhui, MA Zhuo. Current Situation of Potentially Inappropriate Medication in Older Cancer Patients and Strategies to Address It [J]. Chinese General Practice, 2023, 26(35): 4382-4387. |
[5] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[6] | FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358. |
[7] | GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238. |
[8] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[9] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[10] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[11] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[12] | CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun. Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(31): 3890-3895. |
[13] | ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889. |
[14] | DUAN Yanqin, PENG Ying, LIU Shenglan, LIU Haijiao, YANG Huiqiong, HU Haiqing. Prevalence and Associated Factors of Potentially Inappropriate Medication among Elderly Outpatients [J]. Chinese General Practice, 2023, 26(31): 3902-3907. |
[15] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 166
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 429
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||